SHCBP1 and gastric cancer: Supporting findings from aggressive gastric cancer clinical samples with elevated SHCBP1, knockdown of SHCBP1 in gastric cancer cells suppresses the expression of CDK1, CDK4, and cyclin D1, consistent with a block at the G1/S phase transition and reduced cell proliferation [15].